William Gayden is Director at HARTE HANKS INC (HHS). They have made 1 open-market trade across 1 company since 2009, most recently 2013-01-15.
CIK 0001199364
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HHS | 95,179 | $412K |
Shares reported on the most recent Form 4, priced at the 2013-01-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HHS | SELL | 2009-05-08 | 2009-05-11 | $8.65 | $117K | +2.1% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.